KANJINTI Injectable By AMGEN USA INC

Generic Name: Trastuzumab
Options
$1,965.96 / Vial

$1,965.96 / Vial
SKU
KANJINTI-Injectable
Secondary malignant neoplasm of female breast,Secondary malignant neoplasm of stomach,HER2-positive carcinoma of breast
Consult your pharmacist or physician.
Write a Product Review
Write Your Own Review
You're reviewing:KANJINTI Injectable
How do you rate this product?
0/5